Abstract
Cardiac remodeling is one of the principal mechanisms of progression of Heart Failure (HF). The use of beta-blockers (BB) modified the morbidity and mortality of patients with HF, causing reduction of approximately 34% into the risk of death or hospitalization.In addition to the influence on survival of patients with HF, the use of BB promotes reversal of the cardiac remodeling resulting …